SynthesisClinical drug investigation2017

Survival Benefit and Safety of Bevacizumab in Combination with Erlotinib as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: A Meta-Analysis.

Wei Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.